SNSS - Sunesis Pharmaceuticals Inc. (SNSS) CEO Dayton Misfeldt on Q1 2020 Results - Earnings Call Transcript
Sunesis Pharmaceuticals, Inc. (SNSS)
Q1 2020 Earnings Conference Call
May 7, 2020 4:30 PM ET
Company Participants
Par Hyare - Investor Relations
Dayton Misfeldt - Interim Chief Executive Officer
Judy Fox - Chief Scientific Officer, Executive Vice President, Research & Development
Conference Call Participants
Justin Kim - Oppenheimer
Marc Frahm - Cowen
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome to Quarter First 2020 Sunesis Pharmaceutical Incorporated Earnings Conference Call. At this time, all participants’ lines are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session.